老年多重用药多为慢性状态:一项全国性纵向队列研究
该研究基于瑞典全国登记数据,纳入2010年10月使用≥5种处方药的711,432名≥65岁老年人,随访至2013年12月。结果显示82%持续暴露≥6个月、74%≥12个月、55%持续至研究结束;新发多重用药者仅30%持续≥6个月。高龄、女性、机构居住、慢性多病共存和 multidose dispensing 与慢性多重用药相关。
要点
- 老年多重用药多为慢性:82%持续≥6个月,74%≥12个月。
- 新发多重用药者仅30%持续≥6个月,部分为短暂反复暴露。
- 高龄、女性、机构居住、多病共存和多剂量配药与慢性多重用药相关。
核心结论
- 多重用药在老年人中多为慢性状态,但相当一部分老年人经历短暂、反复的多重用药发作。
研究设计与样本
- 纵向队列研究,使用瑞典全国登记数据,纳入2010年10月使用≥5种处方药的711,432名≥65岁老年人,随访至2013年12月。
主要发现
- 总体82%持续暴露于多重用药≥6个月,74%≥12个月,55%持续至研究结束。
- 在基线前6个月未暴露于多重用药的21,361名新发多重用药者中,仅30%持续≥6个月。
- 基线时已存在多重用药者随访期间至少80%时间处于多重用药的比例为80%,新发多重用药者为24%(P < .01)。
- 与慢性多重用药相关的因素包括较高年龄、女性、机构居住、慢性多病共存和多剂量配药。
关键数值与推荐
- 多重用药定义为使用≥5种处方药。
- 持续暴露≥6个月的比例为82%,≥12个月为74%,至研究结束为55%。
- 新发多重用药者持续≥6个月的比例为30%。
- 基线已存在多重用药者中80%随访时间≥80%处于多重用药,新发者为24%(P < .01)。
临床怎么用
- 对老年多重用药患者应认识到其多为慢性状态,需长期进行用药评估与管理。
- 对新发多重用药者应关注其可能为短暂反复暴露,仍需评估潜在危害。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the chronicity of polypharmacy among older adults and to identify factors associated with chronic polypharmacy. DESIGN: Longitudinal cohort study using register data. SETTING: Nationwide, Sweden. PARTICIPANTS: All 711,432 older adults (aged 65 years and older) living in Sweden with five or more prescription drugs in October 2010 were included and followed up until December 2013. Mean age at baseline was 77 (SD = 7.8) years, 59% were women, and 7% lived in nursing homes. MEASUREMENT: Monthly changes in the exposure to polypharmacy. Data regarding prescription drug use were extracted from the Swedish Prescribed Drugs Register. RESULTS: Overall, 82% were continuously exposed to polypharmacy for 6 months or longer, and 74% for 12 months or longer. The proportion of individuals who remained exposed until the end of the study was 55%. Among the 21,361 individuals who had not been exposed to polypharmacy during the 6-month period before baseline (ie, with a new episode of polypharmacy), only 30% remained exposed for 6 months or longer. The proportion of older adults who spent at least 80% of their follow-up time with polypharmacy was substantially higher among prevalent polypharmacy users at baseline than among those with a new polypharmacy episode (80% vs 24%; P < .01). Factors associated with chronic polypharmacy included higher age, female sex, living in an institution, chronic multimorbidity, and multidose dispensing. CONCLUSION: Polypharmacy is most often chronic, although a substantial share of older adults experience short, recurring episodes of polypharmacy and are thus exposed to its potential harms in a transient rather than persistent manner. J Am Geriatr Soc 67:455-462, 2019.
引用
- Wastesson JW, Morin L, Laroche ML, et al. How Chronic Is Polypharmacy in Old Age? A Longitudinal Nationwide Cohort Study. J Am Geriatr Soc. 2018. PMID: 30575952. doi:10.1111/jgs.15717
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。